253 related articles for article (PubMed ID: 18500333)
1. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype.
McMurray HR; Sampson ER; Compitello G; Kinsey C; Newman L; Smith B; Chen SR; Klebanov L; Salzman P; Yakovlev A; Land H
Nature; 2008 Jun; 453(7198):1112-6. PubMed ID: 18500333
[TBL] [Abstract][Full Text] [Related]
2. Cancer: Deconstructing oncogenesis.
Luo J; Elledge SJ
Nature; 2008 Jun; 453(7198):995-6. PubMed ID: 18563141
[No Abstract] [Full Text] [Related]
3. Gene network modeling via TopNet reveals functional dependencies between diverse tumor-critical mediator genes.
McMurray HR; Ambeskovic A; Newman LA; Aldersley J; Balakrishnan V; Smith B; Stern HA; Land H; McCall MN
Cell Rep; 2021 Dec; 37(12):110136. PubMed ID: 34936873
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation.
Zhang B; Shih JW; Wear DJ; Tsai S; Lo SC
Proc Soc Exp Biol Med; 1997 Apr; 214(4):359-66. PubMed ID: 9111527
[TBL] [Abstract][Full Text] [Related]
5. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation.
Milyavsky M; Tabach Y; Shats I; Erez N; Cohen Y; Tang X; Kalis M; Kogan I; Buganim Y; Goldfinger N; Ginsberg D; Harris CC; Domany E; Rotter V
Cancer Res; 2005 Jun; 65(11):4530-43. PubMed ID: 15930270
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.
Sevignani C; Wlodarski P; Kirillova J; Mercer WE; Danielson KG; Iozzo RV; Calabretta B
J Clin Invest; 1998 Apr; 101(8):1572-80. PubMed ID: 9541486
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic potential of BRAF versus RAS.
Benjamin CL; Ananthaswamy HN
Cancer Lett; 2008 Mar; 261(2):137-46. PubMed ID: 18280030
[TBL] [Abstract][Full Text] [Related]
9. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
[TBL] [Abstract][Full Text] [Related]
10. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
[TBL] [Abstract][Full Text] [Related]
11. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
12. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium.
Keller JW; Franklin JL; Graves-Deal R; Friedman DB; Whitwell CW; Coffey RJ
J Cell Physiol; 2007 Mar; 210(3):740-9. PubMed ID: 17133351
[TBL] [Abstract][Full Text] [Related]
14. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis.
Yamada Y; Oyama T; Hirose Y; Hara A; Sugie S; Yoshida K; Yoshimi N; Mori H
Carcinogenesis; 2003 Jan; 24(1):91-7. PubMed ID: 12538353
[TBL] [Abstract][Full Text] [Related]
16. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.
Pollock CB; Shirasawa S; Sasazuki T; Kolch W; Dhillon AS
Cancer Res; 2005 Feb; 65(4):1244-50. PubMed ID: 15735008
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.
Calcagno SR; Li S; Colon M; Kreinest PA; Thompson EA; Fields AP; Murray NR
Int J Cancer; 2008 Jun; 122(11):2462-70. PubMed ID: 18271008
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
20. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
